Financials

  • Market Capitalization 8.63 B
  • Employee 315
  • Founded 2018
  • CEO N/A
  • Website www.immunovant.com
  • Headquarter Delaware, United States
  • FIGI BBG00P5MC0Q8
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-8.97
市销率

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
991
PCVX
Vaxcyte, Inc. - Common Stock
59.86 USD-2.13%-5.75%+9.83%+41.51%8.91 B USD
1000
ABVX
Abivax SA - American Depositary Shares
111.99 USD-2.02%-5.64%-10.34%+36.57%8.80 B USD
1004
IBRX
ImmunityBio, Inc. - Common Stock
8.02 USD-4.52%+2.17%+14.57%+242.74%8.50 B USD
1022
TGTX
TG Therapeutics, Inc. - Common Stock
54.77 USD-1.70%-0.63%-0.18%+88.73%8.38 B USD

新闻